• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to project page

2010 Fiscal Year Final Research Report

Establishment of a novel therapeutic approach for neuroblastoma using replication-compitent HSV-1 virus vector

Research Project

  • PDF
Project/Area Number 20592085
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field Pediatric surgery
Research InstitutionChiba University

Principal Investigator

HISHIKI Tomoro  Chiba University, 大学院・医学研究院, 講師 (00375776)

Co-Investigator(Kenkyū-buntansha) TODO Tomoki  東京大学, 医学部附属病院, 特任教授 (80272566)
YOSHIDA Hideo  千葉大学, 大学院・医学研究院, 教授 (00216194)
SHIRASAWA Hiroshi  千葉大学, 大学院・医学研究院, 教授 (00216194)
SAITO Takeshi  千葉大学, 医学部附属病院, 講師 (20406044)
TERUI Keita  千葉大学, 医学部附属病院, 助教 (70375773)
YAHATA Eriko  千葉大学, 医学部附属病院, 医員 (40456067)
SATO Yoshiharu  千葉大学, 医学部附属病院, 助教 (60375772)
MITSUNAGA Tetsuya  千葉大学, 医学部附属病院, 助教 (80375774)
Co-Investigator(Renkei-kenkyūsha) INO Yasushi  東京大学, 医学部附属病院, 特任准教授 ウイルスベクター開発・指導 (50372371)
Project Period (FY) 2008 – 2010
Keywords神経芽腫 / 腫瘍融解ウイルス / ヘルペスウイルス
Research Abstract

The antitumor effect of genetically modified human herpes simplex virus-1 (T-01) was assessed in human neuroblastoma models in vitro and in vivo. The results showed that T-01 propagates within and potentially kills neuroblastoma cells with a multiplicity of infection of 0.01. 1x10^6 pfu was capable to show significant growth suppression in nude mice neuroblastoma xenografts. However, T-01 was antagonistic against the cytotoxic effect of cisplatin. Thus, co-use of T-01 and anticancer drugs may not be optimal for the therapeutic strategy for neuroblastomas. T-01 may most be effective when targeted for minimum residual diseases.

  • Research Products

    (18 results)

All 2011 2010 2009 2008

All Journal Article (15 results) (of which Peer Reviewed: 6 results) Presentation (2 results) Book (1 results)

  • [Journal Article] Src kinase family inhibitor PP2 induces aggregation and detachment of neuroblastoma cells and inhibits cell growth in a PI3 kinase/Akt pathway-independent manner.2011

    • Author(s)
      Hishiki T, Saito T, Sato Y, Mitsunaga T, Terui E, Matsuura G, Saito E, Shibata R, Mise N, Yokoyama Y, Yoshida H.
    • Journal Title

      Pediatr Surg Int. 27

      Pages: 225-230

    • Peer Reviewed
  • [Journal Article] 悪性脳腫瘍の遺伝子治療2011

    • Author(s)
      藤堂具紀、稲生靖
    • Journal Title

      BIO Clinica 26(4)

      Pages: 33-37

  • [Journal Article] 悪性神経膠腫に対するヘルペスウイルス療法2011

    • Author(s)
      稲生靖、藤堂具紀
    • Journal Title

      Clinical Neuroscience 29(2)

      Pages: 229-231

  • [Journal Article] Clinical development of a third-generation oncolytic HSV-1 (G47Δ) for malignant glioma.2010

    • Author(s)
      Ino Y, Todo T
    • Journal Title

      Gene Therapy and Regulation 5(1)

      Pages: 101-111

    • Peer Reviewed
  • [Journal Article] Oncolytic virus therapy for prostate cancer.2010

    • Author(s)
      Fukuhara H, Homma Y, Todo T.
    • Journal Title

      Int J Urol. 17

      Pages: 20-30

    • Peer Reviewed
  • [Journal Article] Reevaluation of trkA expression as a biological marker of neuroblastoma by high sensitivity expression analysis-a study of 106 primary neuroblastomas treated in a single institute.2010

    • Author(s)
      Hishiki T, Saito T, Terui K, Sato Y, Takenouchi A, Yahata E, Ono S, Nakagawara A, Kamijo T, Nakamura Y, Matsunaga T, Yoshida H.
    • Journal Title

      J Pediatr Surg. 45

      Pages: 2293-2298

    • Peer Reviewed
  • [Journal Article] 悪性脳腫瘍のウイルス療法2010

    • Author(s)
      稲生靖、藤堂具紀
    • Journal Title

      Biotherapy 24(6)

      Pages: 443-447

  • [Journal Article] 悪性脳腫瘍に対するウイルス療法2010

    • Author(s)
      稲生靖、藤堂具紀
    • Journal Title

      日本臨床68(増刊号10新時代の脳腫瘍学-診断・治療の最前線)

      Pages: 473-477

  • [Journal Article] 神経膠腫の遺伝子治療2010

    • Author(s)
      高橋雅道、藤堂具紀
    • Journal Title

      脳神経外科速報 20(7)

      Pages: 798-806

  • [Journal Article] 悪性脳腫瘍に対するウイルス療法2010

    • Author(s)
      稲生靖、藤堂具紀
    • Journal Title

      感染・炎症・免疫 40(1)

      Pages: 81-83

  • [Journal Article] 悪性脳腫瘍に対するウイルス療法2009

    • Author(s)
      稲生靖、藤堂具紀
    • Journal Title

      BRAIN and NERVE 61(7)

      Pages: 815-822

  • [Journal Article] Armed oncolytic herpes simplex viruses for brain tumor therapy.2008

    • Author(s)
      Todo T.
    • Journal Title

      Cell Adh Migr. 2

      Pages: 208-213

    • Peer Reviewed
  • [Journal Article] Oncolytic virus therapy using genetically engineered herpes simplex viruses.2008

    • Author(s)
      Todo T
    • Journal Title

      Frontiers in Bioscience 13

      Pages: 2060-2064

    • Peer Reviewed
  • [Journal Article] ウイルスによる癌治療2008

    • Author(s)
      福原浩、藤堂具紀
    • Journal Title

      ゲノム医学 8(3)

      Pages: 173-181

  • [Journal Article] 脳腫瘍のウイルス療法2008

    • Author(s)
      高橋雅道、藤堂具紀
    • Journal Title

      分子細胞治療 7(2)

      Pages: 129-134

  • [Presentation] Re-evaluation of trkA expression as a biological marker of neuroblastoma by high sensitivity expression analysis ~ a study of 106 primary neuroblastomas treated in a single institute~.2010

    • Author(s)
      Hishiki, T, Saito, T, Terui, K, Sato, Y, Takenouchi, A, Yahata, E, Ono, S, Nakagawara, A, Kamijo, T, Nakamura, Y, Matsunaga, T, Yoshida, H.
    • Organizer
      43^<rd> Annual Meeting of the Pacific Association of Pediatric Surgeons.
    • Place of Presentation
      神戸
    • Year and Date
      2010-05-26
  • [Presentation] 神経芽腫の予後因子としてのTrkA発現高感度解析による再評価2009

    • Author(s)
      菱木知郎, 齋藤武, 照井慶太, 佐藤嘉治, 武之内史子, 八幡江里子, 大野幸恵, 鎌田稔子, 松永正訓, 吉田英生
    • Organizer
      第25回日本小児がん学会(小児がん46増277,2009)
    • Place of Presentation
      浦安
    • Year and Date
      2009-11-27
  • [Book] Active immunotherapy : Oncolytic virus therapy using HSV-1.(In Yamanaka R (ed.))(Glioma : Immunotherapeutic Approaches. Austin TX, Landes Bioscience)2010

    • Author(s)
      Todo T
    • Publisher
      published electronically
    • URL

      https://www.landesbioscience.com/curie/chapter/4898/

URL: 

Published: 2012-01-26   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi